06.3 Periodo di validit CARNITENE 1 g/5 mL soluzione iniettabile per uso endovenoso: 4 anni CARNITENE 2 g/5 mL soluzione iniettabile per uso endovenoso: 3 anni CARNITENE 1 g/10 mL soluzione orale: 5 anni CARNITENE 2 g/10 mL soluzione orale: 3 anni CARNITENE 1,5 g/5 mL soluzione orale: 5 anni CARNITENE 1 g compresse masticabili: 3 anni CARNITENE 1 g/100 mL soluzione per infusione con sodio cloruro: 2 anni CARNITENE 2,5 g/250 mL soluzione per infusione con sodio cloruro: 2 anni CARNITENE 1 g/100 mL soluzione per infusione con glucosio: 1 anno CARNITENE 2,5 g/250 mL soluzione per infusione con glucosio: 1 anno 06.4 Speciali precauzioni per la conservazione Non vi sono da osservare speciali precauzioni per la conservazione
avoid areas with bruising, scarring, or lipohypertrophy, as these impair drug absorption
Carter J, Swardfager W
While curbing appetite is one of the intended outcomes, you dont want to miss out on vital nutrients your body needs
3 The FDA also warned companies of claims that indicate their products are safe and effective for weight loss, including claims that they offer real results or proven effectiveness. 4 Although most of the letters were addressed to compounders, brand name manufacturers that hold FDA approvals also received warnings concerning a prime-time TV special that the FDA says created a misleading impression regarding the safety of their products
While it is believed that semaglutide leads to gastrointestinal disorders less than 5% of the time, transient, mild-to-moderate bouts of the following issues are commonplace among GLP-1 drugs: Nausea : 44% Vomiting: 25% Diarrhea: 32% Constipation: 23% Abdominal pain: 10% Fatigue, Dizziness, Headache Clinical data does not support the idea that semaglutide directly causes dizziness, headaches, or significant fatigue